welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Ureteric Obstruction in Familial Adenomatous Polyposis-Associated Desmoid Disease
source: Diseases of the colon and rectum
year: 2010
authors: Joyce M, Mignanelli E, Church J
summary/abstract:PURPOSE : Intra-abdominal desmoid disease is the second leading cause of death in familial adenomatous polyposis patients. The aim of this study was to identify the incidence, management, and outcomes for familial adenomatous polyposis associated intra-abdominal desmoids causing ureteric obstruction.
METHODS : Clinical data were abstracted from an institutional review board-approved, prospectively maintained familial polyposis registry.
RESULTS : Of 107 patients identified with familial adenomatous polyposis related desmoid disease, 30 (28%) had documented CT scan evidence of ureteric obstruction. There was a 1:2.3 female predominance. Preceding surgery was the most prominent risk factor for development of desmoid disease (28 of 30 patients); 2 patients were diagnosed with desmoids before abdominal surgery. Overall, 11 patients had ureteric obstruction at the time of diagnosis. In the other 19 patients, median time from desmoid diagnosis to ureteric obstruction was 2 years. Pharmacologic management alone was effective in 8 patients. Eighteen patients (60%) underwent retrograde ureteric stent insertion. Five patients (17%) required percutaneous nephrostomy tubes. Three patients (10%) underwent autotransplant of 4 kidneys, and 4 patients (13%) required nephrectomy. One patient underwent ureterolysis, and another underwent ureteric resection with reimplantation. One-third of patients required more than one urologic procedure, and 63% had extensive small-bowel involvement with desmoid.
CONCLUSIONS : The majority of patients with familial adenomatous polyposis associated desmoid disease who develop hydronephrosis require stenting. Complete obstruction may necessitate a nephrostomy. Renal autotransplant is an option for persistent symptomatic obstruction. Physicians treating patients with familial adenomatous polyposis and desmoid disease must be aware of the potential for development of ureteric obstruction and available treatment options.
organization: Cleveland ClinicDOI: 10.1007/DCR.0b013e3181c52894
read more full text source
expertly curated content related to this topic
-
An Evidence-Based, Multidisciplinary Approach to the Clinical Considerations, Management, and Surveillance of Adrena...Adrenal masses are commonly discovered i...
-
Cancer Chemoprevention: A Rapidly Evolving FieldCancer chemoprevention involves the chro...
-
Gardner Syndrome: Skin Manifestations, Differential Diagnosis and ManagementGardner syndrome is a variant of familia...
-
Genetic Counseling and Prognosis of the Development of Complications in Patients with Syndromes of Hereditary Polypo...Physical examinations, genealogic analys...
-
Familial Adenomatous Polyposis of Large IntestineAt present the only treatment of familia...
-
MUTYH-Associated PolyposisMUTYH-associated polyposis (MAP) is an a...
-
Surveillance of FAP: A Prospective Blinded Comparison of Capsule Endoscopy and Other GI Imaging to Detect Small Bowe...BACKGROUND : Familial adenomatous polypo...
English
Portuguese
Spanish